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Condensation is a process whereby a tissue undergoes a coordinated decrease in size and increase in cellular density during development.
Although it occurs in many developmental contexts, the mechanisms underlying this process are largely unknown. Here, we investigate
condensation in the embryonic Drosophila ventral nerve cord (VNC). Two major events coincide with condensation during embryogenesis:
the deposition of extracellular matrix by hemocytes, and the onset of central nervous system activity. We find that preventing hemocyte
migration by removing the function of the Drosophila VEGF receptor homologue, Pvr, or by disrupting Rac1 function in these cells, inhibits
condensation. In the absence of hemocytes migrating adjacent to the developing VNC, the extracellular matrix components Collagen IV,
Viking and Peroxidasin are not deposited around this tissue. Blocking neural activity by targeted expression of tetanus toxin light chain or an
inwardly rectifying potassium channel also inhibits condensation. We find that disrupting Rac1 function in either glia or neurons, including
those located in the nerve cord, causes a similar phenotype. Our data suggest that condensation of the VNC during Drosophila
embryogenesis depends on both hemocyte-deposited extracellular matrix and neural activity, and allow us to propose a mechanism whereby
these processes work together to shape the developing central nervous system.
D 2004 Elsevier Inc. All rights reserved.Introduction
Condensation of tissues during development occurs in a
wide range of contexts. Examples in vertebrates include
mesenchyme during pre-cartilage condensation (DeLise et
al., 2000) and cranial sensory ganglia (Stark et al., 1997).
Another example of condensation during development
occurs in the central nervous systems (CNS) of arthropods.
In these animals, condensation results in fusion of ganglia,
thus imparting a characteristic shape to the CNS (Bullock
and Horridge, 1965).
During Drosophila development, the nerve cord, which is
the ventral part of the central nervous system, undergoes a
coordinated decrease in size toward the end of embryo-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.12.020
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E-mail address: paged@mit.edu (D.T. Page).genesis. Wright (1960) commented that bthe mechanism of
this condensation is obscureQ, and it remains so today. What
we know about the process of VNC condensation during
Drosophila embryogenesis comes from descriptions such as
that presented by Poulson (1965), and scattered reports of
mutants that have defects in this process. One consistent
characteristic of these mutant reports is that either develop-
ment of cells of the nervous system (Buescher and Chia,
1997; Campbell et al., 1994; Doe et al., 1991; Halter et al.,
1995; Speicher et al., 1998; Stroumbakis et al., 1996) or
cellular adhesion (Borchiellini et al., 1996; Brown, 1994;
Lekven et al., 1998; Wright, 1960) is disrupted. Here, we
build on these observations to investigate the mechanisms
underlying VNC condensation.
Two major events that coincide with VNC condensa-
tion in embryonic Drosophila are deposition of extrac-
ellular matrix around tissues in the embryo and the onset
of neural activity in the CNS. We present evidence that
both of these processes are required for normal con-
densation of the VNC. In pvr loss of function mutants,279 (2005) 233–243
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extracellular matrix components around the VNC and
inhibits condensation. Similarly, condensation is impaired
if neural activity is blocked in the embryo. Interfering
with cytoskeleton rearrangement in glia or neurons by
disrupting Rac1 function also results in incomplete
condensation. Based on these data, we discuss here a
mechanism for condensation of the VNC during Droso-
phila embryogenesis.Fig. 1. Method for measuring condensation of the nerve cord in the
anteroposterior axis. Stage 17 y w control embryo stained with anti-Elav,
showing normal condensation. Arrows indicate how measurements of CNS
condensation in the anteroposterior (A–P) axis were taken.Materials and methods
Drosophila stocks
As a non-transgenic control stock, y w flies were
used. All flies were raised at 258C and embryos were
collected at the same temperature. The following strains
were also used (all strains are described in Flybase): vkg-
GFP (G454) homozygous viable GFP trap in the viking
gene, 158-GAL4 (lateral glia driver), gcm-GAL4, crq-
GAL4 (see description below), elav-GAL4 (pan-neuronal
expression), sim-GAL4 (expresses in mesectodermal mid-
line), UAS-PvrDN, UAS-Rac1v12 (activated Rac1), UAS-
Rac1N17 (dominant-negative Rac1), UAS-GFPS65T, UAS-
TeTxLCactive, UAS-TeTxLXinactive, UAS-Vegf27Cb(Pvf2),
UAS-htlDN, Vegfrc2195 (Pvr amorphic allele), htlAB42,
sim2, and UAS-Kir2.1 (Baines et al., 2001). To analyze
basement membrane deposition of Viking collagen IV in
pvr mutants, we recombined vkg-GFP (G454) with
Vegfrc2195. Three independent recombinant lines gave
the same result.
Generation of crq-GAL4 driver
Genomic DNA isolated following standard methods
from y w flies was used as template to amplify the crq
promoter. The following primers were used: sense 5V-
TGCGCCAGTTATCGACAGCTGAG-3V and antisense 5V-
AATAGCCAAGGTGGGAATAATCCAG-3V. This was
followed by a second PCR to introduce a restriction site,
using the same sense primer and 5V-ATCTTGATCAAA-
TAGCCAAGGTGGGAATAATCCAG-3V. The product
was subsequently subcloned into a pCasPeR derivative
containing the ORF of Gal4 (kindly provided by J.
Casal). Germline transformants were generated in y w
background using standard procedures (Rubin and Spra-
dling, 1982). All six independent transformants showed
specific hemocyte expression when crossed to UAS-GFP
flies. We also detected faint expression from this driver in
small cells located regularly along the VNC, one cell per
hemisegment, in the late embryo. Immunostaining with
anti-h-Gal, anti-Elav and anti-Repo in a crq-GAL4, UAS-
lacZ background failed to reveal any co-staining in these
cells, suggesting that they are not neurons or lateral glia;
we do not know the identity of these cells. This,however, does not change our interpretation of the results
presented here.
Immunostaining
All immunohistochemistry was performed using stand-
ard procedures. Staging of embryos was performed as
described (Campos-Ortega and Hartenstein, 1997) and
sufficient embryos were measured to take into account
any slight variations in developmental timing. The primary
antibodies used were: anti-Crq (Franc et al., 1996) (rabbit,
1:1000), anti-Pxn (Nelson et al., 1994) (mouse, 1:1000),
anti-Elav (Developmental Studies Hybridoma Bank
(DSHB)) (rat, 1:100), anti-Repo (Halter et al., 1995)
(rabbit, 1:1000), anti-Fasciclin II (DSHB) (mouse, 1:20),
anti-GFP (kind gift from D. McCusker and R. Arkowitz)
(rabbit, 1:2500), anti-h-galactosidase (DSHB) (mouse,
1:100). The secondary antibodies used in this study were:
biotin-conjugated anti-mouse or anti-rabbit (Jackson),
Alexa Fluor 568-conjugated anti-mouse or anti-rabbit
(Molecular Probes), Alexa Fluor 488-conjugated anti-
mouse or anti-rabbit (Molecular Probes), Cy3-conjugated
anti-mouse or anti-rabbit (Jackson), Cy2-conjucated anti-
mouse or anti-rabbit (Jackson). To obtain transverse views
(Figs. 3 and 4), the embryos were cut at approximately
50% embryo length with fine dissecting needles and the
exposed face of the posterior half of the embryo examined.
For quantification of condensation in embryos where
hemocyte migration was inhibited, we scored hemocyte
migration first, and then measured VNC length.Results
The process of VNC condensation during Drosophila
embryogenesis
Condensation of the CNS along the anteroposterior axis
during Drosophila embryogenesis starts at late stage 15,
with the majority of condensation occurring during stage 16
and early stage 17 (Campos-Ortega and Hartenstein, 1997).
We assessed anteroposterior VNC condensation by measur-
ing the percent embryo length occupied by the VNC in wild
type and mutant animals (Fig. 1). Due to the curvature of the
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measured in this way, although part of the subesophageal
ganglion is also included as this lies at the anterior most
point of the CNS in the embryo at stage 17. In wild type
embryos, condensation results in a shortening of the VNC
from approximately 80% embryo length at stage 15 to
around 60% embryo length at stage 17 (see Table 1). For
movies showing condensation in live embryos, please see
supplementary data.
Disrupting Pvr function or impeding hemocyte migration
inhibits condensation
Drosophila hemocytes are mobile phagocytic blood
cells that synthesize several extracellular matrix compo-
nents (Fessler and Fessler, 1989; Tepass et al., 1994).
Hemocytes recognize and engulf apoptotic cells in a
process that requires the Crq receptor (Franc et al.,
1996; Franc et al., 1999). Crq is specifically expressedTable 1
Measurement of condensation phenotypes











Wild type 20 – 60.3 (3.1) –
Pvrc2195 20 100 75.1 (2.4) b0.0001
gcm-GAL4,
UAS-PvrDN
18 61 66.3 (6.1) 0.0004
158-GAL4,
UAS-PvrDN
26 4 59.6 (2.6) 0.37
engrailed-GAL4,
UAS-Pvf2
20 95 72.3 (3.8) b0.0001
sim-GAL4,
UAS-PvrDN
35 37 63.8 (3.6) 0.0007
crq-GAL4,
UAS-Rac1N17
34 73 67.1 (4.2) b0.0001
crq-GAL4,
UAS-Rac1V12
27 96 70.5 (3.8) b0.0001
elav-GAL4,
UAS-TeTxLCact
35 80 65.4 (3.2) b0.0001
elav-GAL4,
UAS-TeTxLCinact
18 6 61.0 (3.1) 0.48
elav-GAL4,
UAS-Kir2.1
40 33 63.2 (2.5) 0.0003
158-GAL4,
UAS-Rac1N17
20 65 69.6 (8.3) b0.0001
158-GAL4,
UAS-Rac1V12
20 70 68.1 (7.2) 0.0001
htlAB42 20 100 72.4 (4.7) b0.0001
158-GAL4,
UAS-htlDN
16 50 64.4 (4.4) 0.004
elav-GAL4,
UAS-Rac1N17
24 4 60.6 (2.1) 0.71
elav-GAL4,
UAS-Rac1V12
24 67 65.5 (3.2) b0.0001
sim2 19 100 85.8 (4.1) b0.0005
Embryos were measured at stage 17. Penetrance of mutant phenotypes was
assayed by the percentage of embryos in which the VNC occupies 64% or
more of embryo length.on these cells (Franc et al., 1996), and provides a marker
to follow their stereotypic (Cho et al., 2002; Tepass et al.,
1994) migration during embryogenesis. During stages 12
to 14 in wild type embryos, their route goes along the
ventral and dorsal side of the VNC and through the
dorsal–ventral metameric passages located at the midline
of this tissue (neuromeric pores) (Tepass et al., 1994). At
stage 15, hemocytes are excluded from the neuromeric
pores and the number of hemocytes on the ventral surface
of the VNC become progressively reduced through stages
16 and 17.
The presence of hemocytes in the region around the VNC
prior to condensation raises the question of whether this
migration pattern is significant for VNC condensation.
Embryonic hemocyte migration is disrupted by mutations
in Pvr, the Drosophila homologue of VEGF/PDGF receptor
tyrosine kinase (Cho et al., 2002; Heino et al., 2001). In pvr
loss of function embryos, hemocytes initiate their migration
but fail to enter the tail region, and instead clump together in
the anterior of the embryo (Cho et al., 2002) and Fig. 2C).
Strikingly, we observed that the VNC in pvr mutant
embryos is longer than normal at stage 17, indicating that
the VNC does not condense normally in these animals
(Table 1, Fig. 2D). To address whether the condensation
phenotype in pvr mutants is due to a failure in hemocyte
migration, we expressed dominant negative Pvr (PvrDN)
using an early hemocyte driver, glial cells missing (gcm)
GAL4. Hemocyte migration is disrupted in these animals,
and condensation is inhibited (Table 1, Figs. 2E–F). gcm-
GAL4 is also expressed in lateral glia—to verify that Pvr
function is required in hemocytes for VNC condensation,
we expressed PvrDN using the lateral glia driver 158-GAL4.
Condensation is unaffected in these embryos (Table 1), and
the pattern of hemocyte migration appears normal (data not
shown).
The Pvr ligand Pvf2 has been reported to act as a
chemoattractant for hemocytes in vivo (Cho et al., 2002).
We therefore sought to interfere with hemocyte guidance
by misexpressing Pvf2. In embryos where we misex-
pressed Pvf2 using engrailed-GAL4, hemocytes clump
together at distinct areas of the embryo (e.g., around the
proventriculus and the hindgut), and we see no hemocytes
in their normal position around the VNC at any stage (Fig.
2G). These embryos are also inhibited in VNC condensa-
tion (Table 1, Fig. 2H). Endogenous Pvr expression is not
restricted to hemocytes, but is also found in ventral
midline cells (Cho et al., 2002). To investigate whether
this Pvr expression is significant for VNC condensation,
we used single-minded GAL4 to drive PvrDN in the
mesectodermal midline, including midline glia. This
resulted in a partial inhibition of VNC condensation
(Table 1), suggesting that midline Pvr function may
contribute to VNC condensation.
We next wanted to further analyze the contribution of
hemocytes to VNC condensation by specifically inhibiting
hemocyte migration without directly interfering with Pvr
Fig. 2. Contributions of Pvr signaling and hemocytes to condensation. Images A–H and N–O shows lateral views with anterior facing the left. (A) Distribution
of hemocytes at stage 15 in y w embryo. (B) Distribution of hemocytes and normal nerve cord condensation at stage 17 in y w embryo. (C) In the pvr mutant,
the hemocyte aggregate in the anterior part of the embryo. (D) The ventral nerve cord is uncondensed in pvr mutants, the arrow head is pointing to where the
VNC would terminate in a wild type embryo (CNS occupying 60% embryo length). (E) Overexpressing PvrDN with gcm-GAL4 inhibits hemocyte migration
and in most severe cases it phenocopies the pvr mutant. (F) The VNC fails to condense properly. (G) Overexpression of the Pvr ligand Pvf2 disrupts normal
hemocyte migration. (H) VNC condensation is inhibited. (I) Dorsal view of wild type embryo stained with anti-Crq at late stage 14. Notice the distribution of
hemocytes around the brain hemispheres, the foregut (proventriculus), the hindgut and surrounding the dorsal closure. (J) Dorsal view of live embryo late stage
14 expressing GFP with the crq driver. (K–M) crq-GAL4 driving expression of GFP. (K) Cells expressing GFP (primarily nuclear). (L) Peroxidasin-expressing
cells. (M) Merge of (K) and (L), showing co-staining of GFP (red) and Peroxidasin (green). (N) Disruption of hemocyte migration by interfering with Rac1
function using crq-GAL4 to drive activated Rac1. (O) When hemocyte migration is disrupted this leads to a condensation defect.
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embryonic tissues other than hemocytes, and its expression
in the hemocyte lineage is early and transient (Bernardoni et
al., 1997). We therefore made a GAL4 driver that expresses
more specifically in hemocytes. Crq is expressed in these
cells from stage 11, and its expression persists at least
until larval stages (Franc et al., 1996). In contrast to Pvr,
we detected no Crq on midline cells, as assayed using
anti-Crq antibody (data not shown). We used the upstream
promoter elements of crq to generate a crq-GAL4 driver
(see methods). To confirm the hemocyte expression
pattern of this driver, we used it to express GFP—this
showed expression in a pattern similar to that of anti-Crq
staining (Figs. 2I–J, dorsal views with characteristic
hemocyte pattern). Furthermore, GFP-expressing cells co-
stain with another hemocyte marker, anti-Peroxidasin
(Figs. 2K–M).We used crq-GAL4 to inhibit hemocyte migration by
overexpressing dominant negative and constitutively active
forms of Rac1. Rac1 is required for lamellipodia extension,
and cells generally fail to migrate when Rac1 is inhibited
(for review, see (Ridley, 2001)). Dominant negative Rac1
(Rac1N17) and activated Rac1 (Rac1V12) have previously
been shown to inhibit border cell migration (Duchek et al.,
2001; Murphy and Montell, 1996). We found that
expressing Rac1N17 or Rac1V12 with crq-GAL4 also
inhibits hemocyte migration (Table 1, Fig. 2N). This
disruption of migration is clearly detectable by stage 14
for Rac1V12 and by stage 15 for Rac1N17. In both cases,
hemocytes initially migrate out of the head region, but
subsequently lose polarized migration and accumulate in
the anterior of the embryo. Importantly, we also observed
an inhibition of VNC condensation in these embryos
(Table 1, Fig. 2O). These data further support our
Fig. 3. Hemocytes deposit extracellular matrix around the CNS. (A)–(E)
The GFP exon trap in Vkg gene (G454) allows visualization of the
deposition of Collagen IV (Vkg). (A) At stage 13 little deposition is seen.
The inset shows a transverse view with weakly Vkg-positive cells migrating
though the midline pores. (B) At stage 14, the levels are increased and a
thin deposition around the nerve cord is visible. (C) From stage 15 and
onwards the levels around the VNC appears stable, although there is
increased deposition around other internal organs such as gut (D–E).
(F)–(H) Cells expressing Vkg can be identified as hemocytes. (F)
Peroxidasin staining and (G) Vkg-GFP overlap (H).
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VNC condensation.
Deposition of Collagen IV by hemocytes coincides with the
onset of condensation
Hemocytes express several extracellular matrix (ECM)
components such as the enzyme Peroxidasin (Nelson et al.,
1994), basement membrane associated dSPARC (Martinek
et al., 2002), and the proteoglycan MDP-1 (Hortsch et al.,
1998). Hemocytes also produce structural components of
the basement membrane such as LamininA (Kusche-
Gullberg et al., 1992), and the two Collagen IV molecules
identified in Drosophila: Cg25C and Viking (Knibiehler et
al., 1987; Le Parco et al., 1989; Mirre et al., 1988;
Yasothornsrikul et al., 1997).
ECM and basement membrane have important roles in
cell migration and tissue morphogenesis (Brown et al.,
2000; Geiger et al., 2001; Timpl and Brown, 1996). We
therefore hypothesized that hemocytes may lay down
basement membrane components required for the move-
ments accompanying VNC condensation. To examine this
possibility, we visualized when the basement membrane is
laid down around the VNC, using a GFP trap in viking
(vkg) collagen IV as a marker (Morin et al., 2001). In Vkg-
GFP embryos at stage 13, little basement membrane
staining can be seen, but weakly staining hemocytes
migrate through the neuromeric pores (inset transverse
section) and around the VNC (Fig. 3A). At stage 14,
hemocyte staining is more prominent and the basement
membrane is visible, although not discretely localized (Fig.
3B). By stage 15, a well-defined basement membrane is
visible, outlining the surface of the VNC (Fig. 3C). Later in
embryonic development, there is an overall increase in
deposition of Vkg around the gut and other internal organs.
However, Vkg levels around the VNC appear stable from
late stages 15 to 17 (Figs. 3D–E).
Deposition of Collagen IV and Peroxidasin around the VNC
is lost in pvr mutants
Together with the fat body, hemocytes lay down much of
the ECM in the embryo. The deposition of basement
membrane Collagen IV around the nerve cord described
above coincides with the onset of condensation. We
therefore addressed the possibility that hemocyte migration
is important for components of the basement membrane to
be laid down appropriately around the VNC. Consistent
with this, in pvr mutants, no Peroxidasin can be detected in
the ECM surrounding internal organs (Figs. 4A–B), and
there is a severe reduction or absence of basement
membrane Vkg. Vkg around the nerve cord is gone and
generally most Vkg deposition in the embryo is markedly
diminished (Figs. 4C–D). Lateral views verified the
absence of Vkg around the VNC and internal organs (Figs.
4E–F), although Vkg expression in the fat body can still be
Fig. 4. ECM deposition is lost in pvr mutants. (A) Transverse image of a
late 16 wild type embryo showing strong Peroxidasin staining in the
hemocytes and weak staining in the ECM surrounding the internal organs.
(B) In the pvr mutant, the ECM deposition of Peroxidasin is absent, few
hemocytes can be seen dorsally and they still express Peroxidasin albeit at
slightly lower levels (image levels have been increased to make staining
visible). (C) Vkg deposited around the VNC in heterozygous embryos (vkg
GFP, pvr/+) at stage 17. (D) Vkg deposition is lost in the pvr mutant (vkg
GFP, pvr/vkg GFP, pvr). Note that the fat body is expressing Vkg. (E)
Lateral view of a stage 17 embryo showing the distribution of hemocytes
and basement membrane Vkg surrounding internal structures. (F) In the pvr
mutant, the deposition of Vkg is generally severely reduced and lost around
the VNC.
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staining experiments using an antibody against the other
Drosophila Collagen IV, Cg25C (data not shown). Our data
from the pvr mutant indicate that hemocyte migration is
required for extracellular matrix deposition and for VNC
condensation.
Blocking neural activity inhibits condensation of the VNC
The onset of major VNC condensation correlates with
the start of synaptic vesicle-mediated neural activity in the
CNS (16 h after egg laying; (Baines and Bate, 1998)).
Mutants for the t-SNARE Syntaxin, which lack neuro-
transmitter release, have severe condensation defects(Schulze et al., 1995) and unpublished observation),
suggesting a role for transmitter release in condensation.
However Syntaxin also serves important functions in other
processes involving secretion, such as cuticle secretion
(Schulze and Bellen, 1996; Schulze et al., 1995), so the
failure to condense could be an indirect effect of a more
general exocytosis defect. To test more directly if con-
densation is influenced by neural activity, we expressed
tetanus toxin light chain throughout the CNS using a pan-
neuronal driver (elav-GAL4). Tetanus toxin light chain
blocks calcium triggered synaptic vesicle release by cleav-
ing the v-SNARE synaptobrevin (Schiavo et al., 1992).
Targeted expression of this toxin is effective in blocking
synaptic transmission in Drosophila (Martin et al., 2002;
Sweeney et al., 1995). As expected, expressing tetanus toxin
pan-neuronally caused embryonic paralysis. In these
embryos, we see an inhibition of VNC condensation by
25% as compared to wild type embryos (Table 1, Fig. 5A).
Fasciclin II staining verified that gross formation of VNC
axon tracts appears normal (data not shown), in agreement
with Sweeney et al. (1995). As a control, we also expressed
an inactive form of tetanus toxin using elav-GAL4—this did
not affect embryonic VNC condensation (Table 1). Neuro-
nal silencing can also be achieved in Drosophila by
expressing the human inwardly rectifying K+ channel
Kir2.1 (Baines et al., 2001; Nitabach et al., 2002). Pan-
neuronal expression of Kir2.1 also leads to a modest but
significant inhibition of condensation, as well as paralysis
(Fig. 5B, Table 1).
Expressing mutant Rac1 in glia or neurons inhibits VNC
condensation
We next wanted to see if cells of the CNS directly
contribute to VNC condensation. According the hypothesis
of Pipa (1973), glia generates a force to condense the insect
CNS during metamorphosis. A role for glia in embryonic
nerve cord condensation is supported by isolated reports of
mutant phenotypes for genes required for glia development
(Campbell et al., 1994; Halter et al., 1995). Thus, we
thought that glia may generate a force necessary for VNC
condensation, possibly though changes in cell shape and cell
adhesion. We used 158-GAL4 to express Rac1V12 or
Rac1N17 in lateral glia. These mutant forms of Rac have
previously been shown to disrupt migration of peripheral
glia (a subset of lateral glia) and lead to abnormal
ensheathing of axons by these cells (Sepp and Auld,
2003). We found that expressing either mutant form of
Rac1 with 158-GAL4 results in an inhibition of VNC
condensation (Table 1, Fig. 5C). We verified that expressing
mutant Rac1 does not have a gross effect on the differ-
entiation or survival of lateral glia cells using anti-Repo
immunostaining (data not shown).
To further investigate the role of glia in condensation we
examined loss of function mutants for Heartless (Htl), a
Drosophila FGF receptor (Shishido et al., 1993). Most, if
Fig. 5. Contributions of neural cells to VNC condensation. (A through F) All embryos are at stage 17, are viewed laterally, and are stained using anti-Elav
antibody. (A) Embryo expressing active tetanus toxin (TeTxLCactive) pan-neuronally. In these embryos, the VNC is inhibited in condensation. (B) Embryo
expressing Kir2.1 pan-neuronally, showing inhibited condensation of the VNC. (C) Embryo in which activated Rac1 has been expressed in longitudinal glia.
The VNC does not undergo full condensation. (D) heartless (htl) loss of function embryo. The VNC is largely uncondensed. (E) Embryo in which dominant
negative Heartless (htlDN) has been expressed in longitudinal glia. Condensation in the VNC is inhibited in these embryos. (F) Embryo expressing activated
Rac1 under control of the neuronal driver elav-GAL4. In these embryos, the VNC is inhibited in condensation. (G through J) Embryos are at stage 16, and are
viewed ventrally, with anterior to the top of the panel. Staining is with anti-Fasciclin II, which marks a subset of axon tracts. (G) y w control showing normal
pattern of VNC axon tracts. (H) Embryo in which dominant negative Rac1 has been expressed in neurons. Correlating with normal VNC condensation in these
embryos, the pattern of axon tracts appears grossly normal. (I) Embryo expressing activated Rac1 in neurons. The pattern of axon tracts is severely disturbed in
these embryos, correlating with inhibition of VNC condensation. (J) Embryo in which activated Rac1 has been expressed in longitudinal glia. Here, the pattern
of VNC axon tracts is grossly normal.
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glia (also known as longitudinal glia—a subset of lateral
glia), and htl loss of function mutants have defects in the
ensheathing of axon tracts by these cells (Shishido et al.,
1997). We find that the VNC in htl mutant embryos does not
condense normally (Table 1, Fig. 5D). We verified that htl
loss of function embryos are not defective in the gross
pattern of Fasciclin II axon tracts (data not shown), in
agreement with Shishido et al. (1997). Hemocyte migration
also appears normal in htl loss of function embryos (data not
shown).
Htl function is required for the normal development of a
number of tissues outside the CNS during embryogenesis
(Shishido et al., 1997), so we next examined if loss of htl
function in glia can at least partially explain the VNC
condensation phenotype observed in htl mutant embryos. Todo this, we expressed a dominant negative form of Htl in
lateral glia using 158-GAL4. In these embryos, VNC
condensation is inhibited (Table 1, Fig. 5E). This result
argues that Htl function is at least partially required in lateral
glia for normal condensation.
To test if cytoskeleton integrity in neurons is required for
VNC condensation, we expressed Rac1V12 and Rac1N17
with elav-GAL4. Previous studies in Caenorhabditis ele-
gans and Drosophila have shown that Rac function is
required for multiple aspect of axon development such as
growth cone guidance, axon outgrowth, and branch for-
mation (Lundquist, 2003). We found that expression of
Rac1V12 but not Rac1N17 inhibits VNC condensation (Table
1, Fig. 5F). Correlating with abnormal condensation,
expressing Rac1V12 grossly disrupts the pattern of Fasciclin
II axon tracts in the VNC (Fig. 5I), whereas expressing
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condensation phenotype resulting from expressing mutant
Rac1 using 158-GAL4 could be explained by an indirect
effect on neuronal projections. In these embryos, the gross
pattern of axon tracts appears normal (Fig. 5J). While this
does not rule out more subtle defects in VNC axon
scaffolding, this indicates that gross disruption of neuronal
projections cannot explain the condensation defect seen
when mutant Rac1 is expressed in glia.
In summary, we have shown that VNC condensation
requires hemocyte migration, cytoskeletal integrity of glia
and neurons, and neuronal activity: blocking any of these
causes condensation defects. We have attempted to study the
contribution of these processes separately, as far as possible,
by disrupting each individually. However, as expected,
impairing several of these processes in combination causes
the most severe phenotype. For example sim null mutant
embryos are virtually uncondensed, with more than 80% of
the embryo length occupied by the VNC (Table 1). In these
animals, hemocytes fail to migrate to the ventral side of the
VNC and through the neuromeric pores (Cho et al., 2002;
Zhou et al., 1995), midline glia are missing and the
longitudinal axon tracts are fused at the midline (Nambu
et al., 1991).Discussion
Hemocyte migration, ECM and basement membrane
We have shown here that disrupting hemocyte migration
inhibits VNC condensation in the embryo. Lack of
hemocyte migration is associated with a severe reduction
of ECM components (Collagen IV and Peroxidasin)
throughout the embryo and more particularly a loss of these
components around the VNC. This leads us to propose that
correct assembly of the ECM depends on hemocytes, and
that basement membrane is required for condensation.
Supporting a role for ECM in VNC condensation, defects
are observed in loss-of-function mutants of integrins
(Brown, 1994; Wright, 1960), which are ECM receptors
and appear themselves to be required for correct assembly of
basement membranes (Li et al., 2002; Lohikangas et al.,
2001). Mutants in integrins or the ECM component Laminin
A share at least one other phenotype with embryos in which
hemocyte migration has been inhibited: gut morphogenesis
is impaired (Brown, 1994; Yarnitzky and Volk, 1995). Thus,
a dysfunctional ECM may explain several of the morpho-
genetic defects seen in embryos with defective hemocyte
migration.
How might basement membrane contribute to VNC
condensation? Basement membrane may serve as a substrate
for cellular movements involved in condensation and/or
regulate signaling events relevant to condensation (Perrimon
and Bernfield, 2000; Selleck, 2000). Basement membrane is
also required for normal neuromuscular junction develop-ment (Ackley et al., 2003; Carbonetto and Lindenbaum,
1995), and might be part of the functional blood–brain
barrier in Drosophila. Hence, neural function may be
disrupted when basement membrane formation is inhibited.
However, condensation phenotypes in embryos with
impeded hemocyte migration are more severe than in
embryos in which neural activity has been blocked (see
Table 1). This argues that the condensation phenotype seen
in hemocyte migration-blocked embryos cannot be
explained simply by a loss of neural activity.
Although animals in which hemocyte migration is
blocked fail to deposit Collagen IV appropriately, we have
not demonstrated that Collagen IV function is required for
condensation. However, embryos expressing a dominant
negative form of Collagen IV under the control of a
heatshock promoter fail to condense their nerve cord
(Borchiellini et al., 1996). While these data point towards
a functional role of Collagen IV in condensation, further
studies will be necessary to clarify the specific role of
Collagen IV during condensation.
We have not investigated whether phagocytosis of cells
within the VNC contributes to condensation. pvr mutants
show a perdurance of unengulfed cells at the ventral surface
of the CNS at stage 14 (data not shown). The majority of
these cells seem to disappear later, possibly engulfed by
epidermal cells. pvr mutants also maintain some very
restricted points of attachment between the epidermis and
the VNC. We did not observe this phenotype when we
blocked hemocyte migration using mutant Rac1 expressed
by crq-GAL4. This likely reflects failure of hemocyte
migration at a later stage, after the two tissues have
separated.
The major cell type that engulfs apoptotic corpses within
the CNS is the subperineural glia (Sonnenfeld and Jacobs,
1995). In the absence of macrophages (in the Bic-D
mutants), apoptotic cells are still expelled from the CNS
but accumulated at the ventral surface (Sonnenfeld and
Jacobs, 1995), similar to our observations in the pvr
mutant. Sears et al. (2003) recently reported that hemocytes
are required for normal CNS morphogenesis: at stage 16
pvr mutants and Crq RNAi treated embryos have misposi-
tioned glia and minor axon scaffolding defects. They
interpreted their data to reflect a failure of engulfment of
cell corpses. In the context of our findings, an additional
cause for glial mispositioning in pvr mutant embryos could
be a loss of basement membrane components and the
failure to condense.
Synaptic activity
VNC condensation correlates with the onset of neural
activity in the CNS, and we find that expressing tetanus
toxin light chain or the inwardly rectifying K+ channel
Kir2.1 pan-neuronally impairs condensation. This suggests
that neural activity influences normal condensation. Neural
activity could contribute to condensation in multiple ways.
B. Olofsson, D.T. Page / Developmental Biology 279 (2005) 233–243 241It could directly regulate cellular events relevant to
condensation, such as adhesion (Murase et al., 2002) or
actin-based motility (Matus, 2000), or activity could
influence the transcription of genes relevant to such events
(Bito et al., 1996). Alternatively, neural activity could
maintain synaptic connectivity among cells necessary for
condensation, rather than directing changes in cellular
behavior leading to condensation. Some condensation
occurs before neural activity begins, and the condensation
phenotypes resulting from impeding hemocyte migration are
more severe than those resulting from blocking neural
activity. This suggests that there may be multiple stages of
condensation, including an earlier activity-independent
stage and a later stage that is influenced by activity.
Glia and neurons: what drives condensation?
We have also shown here that VNC condensation can be
inhibited by expressing mutant Rac1 in lateral glia or
neurons. In glia, migration and ensheathing behaviors
require cytoskeletal integrity. When mutant Rac1 is
expressed in peripheral glia, the formation of cellular
extensions is disrupted, and this is accompanied by glia
migration and axon ensheathment defects (Sepp and Auld,
2003). Similarly, ensheathment of longitudinal axon tracts by
longitudinal glia is disrupted in htl loss of function embryos
(Shishido et al., 1997). We interpret the VNC condensation
phenotype in these embryos as indication that glia need
dynamic actin cytoskeleton to generate a condensing force.
Two types of VNC glia are particularly well placed to
generate such a force: longitudinal glia associated with VNC
longitudinal connectives, and perineural glia, which
ensheath the cortex of the VNC (Campos-Ortega and
Hartenstein, 1997). Cell–cell contacts and cell–ECM con-
tacts among these cells accompanied by remodeling of
extracellular matrix could help generate a condensing force
within and across neuromeres through changes in cell shape,
adhesion or migration. A similar process occurs during
mesenchymal condensation (DeLise et al., 2000).
In neurons, neurite extension requires normal Rac
GTPase activity. Expressing mutant Rac1 in these cells
causes defects in axonal outgrowth (Luo et al., 1994). In wild
type animals, VNC axons are arranged into longitudinal
connectives that extend along the length of the nerve cord,
and these are well placed to generate an anteroposterior
condensing force. This could happen through differential cell
adhesion of neurites within the longitudinal connectives or
overall shortening of the axons. The observation that axons
in VNC longitudinal connectives loop out during condensa-
tion in metamorphic insects (Pipa, 1973; Schwager-Hubner,
1970) is consistent with this idea. It is interesting to note that
condensation is inhibited in embryos in which mutant Rac1
is expressed in glia, but longitudinal axon tracts appear
normal in these animals (see Fig. 5J). This suggests to us that
if axons help generate a condensing force, they likely do this
with the help of glia, possibly using these cells as a substrate.It is also possible that at least part of the force required for
condensation may come from outside the VNC. Somatic
muscles connect to the VNC during embryogenesis (Poulson,
1965), and embryonic muscle activity toward the end of
embryogenesis is well timed for generating such a force.
Also, the methods used to manipulate glia or neuron
development in this study may affect neuromuscular activity
by disrupting blood–brain barrier formation, or by affecting
the Rac-dependent formation of synaptic structures (Luo,
2000; Nakayama et al., 2000; Weston et al., 2000). However,
the observation that the CNS can condense in mutants in
which muscles do not form normally (Bloor and Brown,
1998;Wright, 1960) argues against a major contribution from
muscle activity.
Our data identify several areas for further investiga-
tion. First, by following the behavior of small populations
of cells in the VNC it may possible to analyze in vivo
changes associated with the condensation process and get
insight into how changes in organ shape are generated
and coordinated. Second, it will also be interesting to
examine the contributions made by components of the
ECM to normal blood–brain barrier function. Finally, it
may be possible to use VNC condensation in embryonic
Drosophila to investigate the molecular and cellular basis
of how neural activity is translated into a morphogenetic
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